EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications

Yuanfang Shi, Qingxue Zhou, Shilei Dong, Qi Zhao, Xue Wu, Peng Yang, Xiaoyan Zeng, Xinggui Yang, Yan Tan, Xinhua Luo, Zhenghua Xiao, Xu Chen

BMC Microbiology · 28.02.2024 · 24 (1)

DOI: 10.1186/s12866-024-03220-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 28.02.2024. Verfasst von Yuanfang Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China. Hauptthemen laut MEDLINE: Metal Nanoparticles, Hepatitis C, Biosensing Techniques. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Medical Scientific Research Foundation of Zhejiang Province, the Program of Key Laboratory of Higher Education in Guizhou Province, the NATCM's Project of High-level Construction of Key TCM Disciplines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In the current study, for the first time, we reported a novel HCV molecular diagnostic approach termed reverse transcription loop-mediated isothermal amplification integrated with a gold nanoparticles-based lateral flow biosensor (RT-LAMP-AuNPs-LFB), which we developed for rapid, sensitive, specific, simple, and visual identification of HCV.

Methods

A set of LAMP primer was designed according to 5’untranslated region (5’UTR) gene from the major HCV genotypes 1b, 2a, 3b, 6a, and 3a, which are prevalent in China. The HCV-RT-LAMP-AuNPs-LFB assay conditions, including HCV-RT-LAMP reaction temperature and time were optimized. The sensitivity, specificity, and selectivity of our assay were evaluated in the current study. The feasibility of HCV-RT-LAMP-AuNPs-LFB was confirmed through clinical serum samples from patients with suspected HCV infections.

Results

An unique set of HCV-RT-LAMP primers were successfully designed targeting on the 5’UTR gene. The optimal detection process, including crude nucleic acid extraction (approximately 5 min), RT-LAMP reaction (67℃, 30 min), and visual interpretation of AuNPs-LFB results (~ 2 min), could be performed within 40 min without specific instruments. The limit of detection was determined to be 20 copies per test. The HCV-RT-LAMP-AuNPs-LFB assay exhibited high specificity and anti-interference.

Conclusions

These preliminary results confirmed that the HCV-RT-LAMP-AuNPs-LFB assay is a sensitive, specific, rapid, visual, and cost-saving assay for identification of HCV. This diagnostic approach has great potential value for point-of-care (POC) diagnostic of HCV, especially in resource-challenged regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesHepatitis CBiosensing TechniquesHumansHepacivirusGoldSensitivity and Specificity5' Untranslated RegionsNucleic Acid Amplification TechniquesMolecular Diagnostic Techniques

Stichwörter der Autor:innen

BiosensorHepatitis C virusLimit of detectionPoint-of-care platformReverse transcription loop-mediated isothermal amplification

Substanzen

Gold5' Untranslated Regions

Autor:innen und Institutionen

  • The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China.
  • Central Laboratory of the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China.
  • Clinical Laboratory, Hangzhou Women's Hospital, Hangzhou, Zhejiang, 310008, People's Republic of China.
  • Department of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, 310013, People's Republic of China.
  • Department of gastroenterology, the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China.
  • Department of Scientific Research, the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China.

Förderung

  • the Medical Scientific Research Foundation of Zhejiang Province
  • the Program of Key Laboratory of Higher Education in Guizhou Province
  • the NATCM's Project of High-level Construction of Key TCM Disciplines
  • Program of Science and Technology of Guizhou Provincial Health Commission
  • the Guizhou Provincial Key Technology R&D Program
  • the NATCM’s Project of High-level Construction of Key TCM Disciplines

Zitieren

APA

Shi, Y., Zhou, Q., Dong, S., Zhao, Q., Wu, X., Yang, P., Zeng, X., Yang, X., Tan, Y., Luo, X., Xiao, Z., & Chen, X. (2024). Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03220-9

Vancouver

Shi Y, Zhou Q, Dong S, Zhao Q, Wu X, Yang P, et al. Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications. BMC Microbiology. 2024;24(1). doi:10.1186/s12866-024-03220-9

BibTeX
@article{Shi2024,
  author = {Shi, Yuanfang and Zhou, Qingxue and Dong, Shilei and Zhao, Qi and Wu, Xue and Yang, Peng and Zeng, Xiaoyan and Yang, Xinggui and Tan, Yan and Luo, Xinhua and Xiao, Zhenghua and Chen, Xu},
  title = {Rapid, visual, label-based biosensor platform for identification of hepatitis C virus in clinical applications},
  journal = {BMC Microbiology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12866-024-03220-9}
}
Kostenlos starten →